What is LunaRich?
Epigenetics – Think of it this way: who you are is written in both pen and pencil. Things written in pen you can’t change. That’s DNA. But things written in pencil you can. That’s epigenetics.
Reliv’s exclusive non-GMO LunaRich delivers five to ten times the amount of lunasin that provides many of soy’s documented health benefits through epigenetics. Numerous studies demonstrate lunasin’s superior support for cancer-preventive effects, cardiovascular health, immune system support, significant anti-inflammatory properties, anti-aging, skin health, and more…
LunaRich products are quite simply the most advanced soy formulations on the market today — and they’re available only from Reliv.
LunaRich is a Reliv-exclusive nutritional ingredient with multiple patents protecting the LunaRich technology as it relates to enhancing lunasin bioactivity and its superior ability to deliver bioactive lunasin to the body. “This patent enhancement is the latest exciting development in the LunaRich story,” said Dr. Carl W. Hastings, Reliv vice chairman and chief scientific officer. “Ingredients like LunaRich that boast a spectrum of nutritional technologies often require continual patent updates, and LunaRich’s unique ability to be absorbed by the body is essential to its unparalleled efficacy. Reliv is committed to securing the strongest patent portfolio possible for this remarkable nutritional ingredient.”
Reliv holds an additional patent related to LunaRich’s mechanism of action for lowering cholesterol. Learn more about the cholesterol lowering properties of LunaRich.
LunaRich’s Superior Bioavailability
LunaRich’s unique refinement process retains a more uniform and integrated “shell” of protease inhibitors, which serve as protective chaperone molecules to better protect the lunasin from being destroyed in the stomach. The shell is then broken down to allow for maximum absorption of lunasin in the small intestine, where it can provide the greatest benefit. Learn more about the bioavailability of LunaRich.
“We have demonstrated through our exclusive bioassay, based on lunasin’s proprietary epigenetic mechanism of action, that LunaRich products maintain lunasin’s bioactivity after digestion,” said Dr. Alfredo Galvez, lead scientific advisor at SL Technology, Inc., a Reliv subsidiary. “It is the only test of its kind in the supplement industry and gives Reliv the unique ability to guarantee the bioactivity and bioavailability of lunasin in its LunaRich products. Now we have additional patent protection for the novel formulations that make LunaRich products so effective in delivering all the health benefits of lunasin.”